PERK
抑制剂选择性比较
PERK产品
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S7307 |
GSK2606414GSK2606414 是一种口服具有生物活性的,有效的,选择性PERK抑制剂,IC50 为 0.4 nM,比测试的其他EIF2AKs选择性至少高100倍。GSK2606414 可在具有MYCN扩增作用的NB细胞中抑制GANT-61诱导的自噬。GSK2606414 可加剧HCT116细胞中内质网应激诱导的凋亡,而降低SIL1 KD HeLa细胞中的凋亡。 |
![]() ![]() GSK2606414 decreased the number of TUNEL-positive neurons at 72 h after SAH. Representative microphotographs showed the colocalization of NeuN (red) with TUNEL (green)-positive cells in the bilateral basal cerebral cortex at 72 h after SAH (a). Quantitative analysis of TUNEL-positive neurons showed that GSK2606414 decreased the number of apoptotic cells after SAH (b). Scale bar=100 μm, *p < 0.05 versus sham; #p < 0.05 versus SAH + vehicle; ξp < 0.05 versus SAH+GSK2606414 (30 μg). |
|
S7033 |
GSK2656157GSK2656157 是一种ATP竞争性的高选择性PERK抑制剂,无细胞试验中IC50为0.9 nM, 比作用于一组300种激酶选择性高500多倍。GSK2656157可减少凋亡并抑制过度的自噬。 |
![]() ![]() GSK2656157 inhibits excessive autophagy in kri1lcas002 HSPCs. Representative confocal images of mCherry-Lc3 puncta (autophagosomes) in kri1lcas002 mutant embryos in Tg (cmyb: egfp) transgenic background are shown. Scale bars, 5 μm.
|
|
S7400 |
ISRIB (trans-isomer)ISRIB(trans-isomer), 反式异构体ISRIB, 是一种高度选择性PERK抑制剂,其IC50为5 nM. 对非应激细胞的翻译、转录或是mRNA的稳定性没有广泛作用。 |
![]() ![]() PERK inhibitor treatment restores female development in zar1 homozygous mutants. Juveniles were treated with two PERK inhibitors from 22 dpf to 60 dpf. Final concentration: ISRIB, 50 nM. **P<0.01, ***P<0.001.
|
|
S2923 |
SalubrinalSalubrinal是一种选择性eIF2α去磷酸化抑制剂,可以抑制ER应激介导的细胞凋亡,无细胞试验中EC50约为15 μM。 |
![]() ![]() AngII (30 minutes)-induced Akt activation was attenuated by the ER stress inhibitors 4-PBA (5 mM, 2 hours), TUDCA (300 µg/ml, 1 hour), and salubrinal (30 µM, 1 hour) (n=5; *P<0.01 versus con, #P<0.05 versus Ang) |
|
S7437 |
Sal003Sal003 是一种有效的细胞渗透性eIF-2α phosphatase抑制剂。 |
||
S8304 |
AzoramideAzoramide是非折叠蛋白质应答UPR的小分子调节剂,可改善内质网蛋白折叠能力,激活ER伴侣蛋白能力,保护蛋白免受内质网应激反应。 |
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S7307 |
GSK2606414GSK2606414 是一种口服具有生物活性的,有效的,选择性PERK抑制剂,IC50 为 0.4 nM,比测试的其他EIF2AKs选择性至少高100倍。GSK2606414 可在具有MYCN扩增作用的NB细胞中抑制GANT-61诱导的自噬。GSK2606414 可加剧HCT116细胞中内质网应激诱导的凋亡,而降低SIL1 KD HeLa细胞中的凋亡。 |
![]() ![]() GSK2606414 decreased the number of TUNEL-positive neurons at 72 h after SAH. Representative microphotographs showed the colocalization of NeuN (red) with TUNEL (green)-positive cells in the bilateral basal cerebral cortex at 72 h after SAH (a). Quantitative analysis of TUNEL-positive neurons showed that GSK2606414 decreased the number of apoptotic cells after SAH (b). Scale bar=100 μm, *p < 0.05 versus sham; #p < 0.05 versus SAH + vehicle; ξp < 0.05 versus SAH+GSK2606414 (30 μg). |
|
S7033 |
GSK2656157GSK2656157 是一种ATP竞争性的高选择性PERK抑制剂,无细胞试验中IC50为0.9 nM, 比作用于一组300种激酶选择性高500多倍。GSK2656157可减少凋亡并抑制过度的自噬。 |
![]() ![]() GSK2656157 inhibits excessive autophagy in kri1lcas002 HSPCs. Representative confocal images of mCherry-Lc3 puncta (autophagosomes) in kri1lcas002 mutant embryos in Tg (cmyb: egfp) transgenic background are shown. Scale bars, 5 μm.
|
|
S7400 |
ISRIB (trans-isomer)ISRIB(trans-isomer), 反式异构体ISRIB, 是一种高度选择性PERK抑制剂,其IC50为5 nM. 对非应激细胞的翻译、转录或是mRNA的稳定性没有广泛作用。 |
![]() ![]() PERK inhibitor treatment restores female development in zar1 homozygous mutants. Juveniles were treated with two PERK inhibitors from 22 dpf to 60 dpf. Final concentration: ISRIB, 50 nM. **P<0.01, ***P<0.001.
|
目录号 | 产品描述 | 文献引用 | 实验数据 |
---|---|---|---|
S2923 |
SalubrinalSalubrinal是一种选择性eIF2α去磷酸化抑制剂,可以抑制ER应激介导的细胞凋亡,无细胞试验中EC50约为15 μM。 |
![]() ![]() AngII (30 minutes)-induced Akt activation was attenuated by the ER stress inhibitors 4-PBA (5 mM, 2 hours), TUDCA (300 µg/ml, 1 hour), and salubrinal (30 µM, 1 hour) (n=5; *P<0.01 versus con, #P<0.05 versus Ang) |
|
S7437 |
Sal003Sal003 是一种有效的细胞渗透性eIF-2α phosphatase抑制剂。 |
||
S8304 |
AzoramideAzoramide是非折叠蛋白质应答UPR的小分子调节剂,可改善内质网蛋白折叠能力,激活ER伴侣蛋白能力,保护蛋白免受内质网应激反应。 |